CatalystWireBeta

Dr. Martens

DOCS · Main Market · Consumer Products and Services · mcap £651m · 68.9p

Beta Briefing, track record and signals & risks are not ready for Dr. Martens yet.

We follow 964 UK small caps and every one of their announcements – often hundreds per company. 73 companies are already wired into a briefing: browse them.

Key announcements Monitoring checked today, 05:35

DateTypeAnnouncementDay
07 Oct 26 Group Reporting Changes
Dr. Martens moves to market-based reporting with US and Global Markets segments effective FY27.
+2.6%
24 Sep 26 Launch of 'With Bouncing Soles' Brand Platform
Dr. Martens launches 'With Bouncing Soles' brand platform with new ecommerce site and four Brand Centre store openings this autumn.
+0.7%
06 Aug 26 Board change Appointment of Independent Non-Executive Director
Alia Gogi appointed as Independent Non-Executive Director, effective 1 September 2026.
+2.0%
15 Jul 26 Trading update AGM Trading Update
FY27 guidance unchanged; trading in line with expectations; on track with strategic objectives.
+2.1%
01 Jul 26 NED Appointment and Committee Changes
Melanie Richards appointed Independent Non-Executive Director and Senior Independent Director from 15 July 2026.
+2.6%
02 Jun 26 Results Annual Report
2026 Annual Report and Notice of Annual General Meeting
+0.7%
27 May 26 Board change Directorate Change
Senior Independent Director Lynne Weedall to step down at July 2026 AGM after six years.
+4.1%
19 May 26 EBT Share Purchase
The Company announces that it has recommended that FCM Trust Limited (the "Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit Trust (the "Trust"), purchases up to 10m ordinary shares of the Comp
+3.3%
19 May 26 Results FY26 Results
FY26 adjusted PBT up 61% to £55.0m as business pivots to consumer-first model, revenue in line with guidance.
+3.3%
08 Apr 26 Appointment of Market General Managers
Dr. Martens restructures to market general manager model with new executive team led by CEO Nwokorie.
+5.6%
29 Jan 26 EBT Share Purchase
The Company announces that it has recommended that FCM Trust Limited (the "Trustee"), in its capacity as trustee of the Dr Martens plc Employee Benefit Trust (the "Trust"), purchases up to 10m ordinary shares of the Comp
+2.9%
27 Jan 26 Trading update Q3 FY26 Trading Statement
Q3 revenue down 2.7% on constant currency; wholesale up 9.5% but DTC down 6.5% as promotions cut.
−11.6%
20 Nov 25 Results H1 FY26 Results
H1 FY26 revenue flat at £322m; adjusted PBT loss improved to £9.2m; full price DTC revenue up 6%.
−9.6%
10 Oct 25 Appointment of joint corporate broker
Martens plc announces the appointment of Berenberg as joint corporate broker, to work alongside Investec and Goldman Sachs, with immediate effect.
−3.4%

Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note